Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Updated: Oct 21 2017

Toxic Shock Syndrome

Snapshot
  • A previously healthy 18-year-old female comes into the acute care clinic with a day history of nausea, vomitting and diarrhea. She admits to currently menstruating and using tampons, which she does not change frequently. Temperature is 103°F (39.4°C), blood pressure 95/60 mmHg and pulse is 108/min. She is ill appearing on exam. Skin evaluation reveals a diffuse macular erythematous rash. Complete blood cell findings included a WBC of 14,000/mm3. Blood cultures were negative.
Introduction
  • Toxic shock syndrome (TSS)
    • caused by pre-formed S. aureus toxin TSST-1
      • acts as a superantigen → non-specific clonal T-cell activation and cytokine outpouring
  • Associated with high absorbency tampon use in reproductive females
  • Seen in surgical and postpartum would infections and burns
Presentation
  • Symptoms
    • occurs within 5 days of onset of menstrual period in women using tampons
    • fever, vomiting, diarrhea
  • Physical symptoms
    • hypotension
    • diffuse, macular erythematous rash
    • desquamation of palms and soles
      • occurs during recovery
    • conjunctival-scleral hemorrhage
Evaluation
  • Clinical diagnosis
  • Labs
    • culture wound and mucosal sites
    • negative blood and CSF cultures
Differential
  • Streptococcal toxic shock syndrome
    • caused by pyogenic exotoxin A and C of S. pyogenes
      • acts as a superantigen → non-specific clonal T-cell activation and cytokine outpouring
  • Rocky mountain spotted fever
  • Meningococcemia
Treatment
  • Rehydration
  • Remove offending agent
    • menstrual products (e.g., tampons, nasal packing)
    • infected tissue
  • Intravenous antibiotics
    • clindamycin and vancomycin or linezolid
      • change antibiotic once drug-sensitivities are obtained
Prognosis, Prevention, Complications
  • Prognosis
    • menstrual TSS mortality declined
    • nonmenstrual TSS mortality seems to remain stable
  • Prevention
    • not well established
  • Complications
    • renal involvement
    • CNS manifestations
Question
1 of 3
Private Note

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options